Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Daniel Serra de Carvalho"'
Autor:
Eliezer J. Barreiro, Euzenir Nunes Sarno, Tercia R. Alves, José Augusto da Costa Nery, Elizabeth P. Sampaio, Lídia Moreira Lima, Daniel Serra de Carvalho
Publikováno v:
Current Bioactive Compounds. 8:167-175
Autor:
Ulisses Gazos Lopes, Elizabeth P. Sampaio, Euzenir Nunes Sarno, José Augusto da Costa Nery, Daniel Serra de Carvalho
Publikováno v:
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry. 5:71-77
Novel discoveries in medicine have provided understanding of the mechanisms involved in the development and maintenance of pathologies, thereby leading to the identification of new therapeutic targets and consequently new drugs. Thalidomide, independ
Autor:
Michael U. Shiloh, Christa S. Zerbe, Susan E. Hoover, Li Ding, Douglas B. Kuhns, Vivek Ramarathnam, Christine Spalding, Mohammed A. Sadat, David E. Greenberg, Joseph Pechacek, Michelle L. Paulson, Elizabeth P. Sampaio, Lindsey B. Rosen, Dalton L. Dias, Daniel Serra de Carvalho, Gulbu Uzel, Donald C. Vinh, Brendan De Marco, Hannelore I. Bax, Michael Alvares, Joshua D. Milner, Amy P. Hsu, Henry E. Wiley, Ileana Moreira, Daniel Johnson, Sarah K. Browne, Shrimati Datta, John N. Galgiani, Jason Gillman, Maria Teresa De La Morena, Sergio D. Rosenzweig, Steven M. Holland, Debra A. Long Priel, Prabha Chandrasekaran, Liliana Bezrodnik
Publikováno v:
Journal of Allergy and Clinical Immunology, 131(6), 1624-+. Mosby Inc.
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Background: Impaired signaling in the IFN-g/IL-12 pathway causes susceptibility to severe disseminated infections with mycobacteria and dimorphic yeasts. Dominant gain-of-function mutations in signal transducer and activator of transcription 1 (STAT1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32d7615e0d7f330060597a2f10b78730
https://pure.eur.nl/en/publications/fe2bbf24-f196-4105-bd6a-935fe2f5ebed
https://pure.eur.nl/en/publications/fe2bbf24-f196-4105-bd6a-935fe2f5ebed
Autor:
Renata T Paiva, Elizabeth P. Sampaio, Euzenir Nunes Sarno, Jorgenilce S. Sales, Ulisses Gazos Lopes, Alessandra Mattos Saliba, Daniel Serra de Carvalho, Flávio Fonseca Nobre, Tatiana de Oliveira Fulco
Publikováno v:
BMC Research Notes
BMC Research Notes, Vol 5, Iss 1, p 292 (2012)
BMC Research Notes, Vol 5, Iss 1, p 292 (2012)
Background Thalidomide is an anti-inflammatory and anti-angiogenic drug currently used for the treatment of several diseases, including erythema nodosum leprosum, which occurs in patients with lepromatous leprosy. In this research, we use DNA microar